Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial – The Lancet Respiratory Medicine Commentary: Commonly used blood pressure medications safe for COVID-19 patients, study finds – University of Pennsylvania School of Medicine   NEW Research—renin–angiotensin system inhibitors can be safely continued in patients admitted […]

The post Randomized trial: Renin–angiotensin system inhibitors can be safely continued in patients admitted to hospital with COVID-19 appeared first on Links Medicus.